Population Health (129)

Dr. Carrie Nelson, chief medical officer at KeyCare, explains how IT leaders should strategize for telehealth's role in the annual surge, the fit with managing chronic conditions, boosting seniors' annual wellness visits, and more.

Tracking symptoms has been shown to help patients live 30% longer than those who don't write down how they feel, says radiation oncologist Dr. Raghav Murali-Ganesh, cofounder and CEO of Osara Health.

HIMSS Chief Scientific Research Officer Anne Snowdon examined Leapfrog data on 2,000 U.S. hospitals and found a direct link between achieving EMRAM Stage 6 or 7 and higher quality and safety results.

Kauvery Hospital founder Dr Manivannan Selvaraj narrates their group's two-decade digital transformation that began with a single computer.

Real-time performance metrics give Children's Health Alliance providers more information at the point of care and reduce their burdens meeting value-based incentive targets, says Julie Harris, senior director of population health.

Keenan Wyrobek, cofounder and CTO of Zipline, explains the value of implementing long-range drones into prescription delivery, lab services and other operations.

Hal Wolf, HIMSS president and CEO, talks about how signing a Memorandum of Understanding with South Korea's Health Information Service will help measure digital maturity of the country's hospitals and support workforce development.

Jerry Shultz, president at Lightbeam Health Solutions, talks about how the company uses predictive analytics and AI to help payers and health systems determine patients' risk profiles and assign them to the most appropriate care path.

Dr. Omar Manejwala, chief medical officer at DarioHealth, discusses the company's experience with self-insured employers bending costs by employing digital therapeutics while simultaneously supporting individuals with chronic conditions.

Felix Lee, head of organizational capability and transformation at Sanofi, relays how the pharma company leverages DarioHealth's digital therapeutics to complement its drug offerings and gather a comprehensive picture of a patient's health.

Amos Adler, founder, and president at Memotext, discusses his company's flagship digital app for the schizophrenia and psychosis population and how its portal helps caregivers engage with patients and identify the risks for relapse and readmission.

Meg Barron, Peterson Health Technology Institute's managing director of engagement and outreach, relays how the organization independently evaluates digital health offerings' clinical efficacy, budget impact, and return on investment.